Anemia
8 competing products in clinical development for Anemia.
Pipeline by Phase
Phase 12
Phase 21
Phase 34
Approved1
All Products (8)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Aranesp® | Amgen | Approved | Completed | 43 |
| epoetin beta + placebo | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| darbepoetin alfa | Amgen | Phase 3 | Completed | 40 |
| Roxadustat + Epoetin alfa + Darbepoetin alfa + Iron | Astellas Pharma | Phase 3 | Completed | 40 |
| darbepoetin alfa | Kyowa Kirin | Phase 3 | Completed | 40 |
| darbepoetin alfa | Kyowa Kirin | Phase 2 | Completed | 35 |
| LY2787106 | Eli Lilly | Phase 1 | Completed | 29 |
| roxadustat | Astellas Pharma | Phase 1 | Completed | 29 |